Emtricitabine And Tenofovir Disoproxil Fumarate Tablet
Product Images NDC 51407-112

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 51407-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-112-30.jpg (51407 112 30)

Label for Emtricitabine and Tenofovir Disoproxil Fumarate tablets, 200 mg / 300 mg strength, from Golden State Medical Supply, Inc. The label indicates the package contains 30 tablets and includes storage instructions, usage warnings, and manufacturer information for Strides Pharma Global Pte. Ltd. The label also features a barcode and a QR code area for lot, expiration, and serial numbers.*

FDA Label Image

Structure (5222ff1f 65db 4944 859c 2dc73afb9d83 01)

Chemical structure of the active ingredient Emtricitabine and Tenofovir Disoproxil Fumarate. The diagram shows molecular bonds and atoms arranged to depict the chemical formula of this antiviral compound used in oral tablet form by Golden State Medical Supply, Inc.*

FDA Label Image

Structure (5222ff1f 65db 4944 859c 2dc73afb9d83 02)

Chemical structure diagram of the active ingredient Tenofovir Disoproxil Fumarate shown with connected atoms and functional groups as part of the pharmaceutical product Emtricitabine and Tenofovir Disoproxil Fumarate tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.